Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2022-10-27 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled for November 3, 2022, to consider and approve the standalone unaudited financial results for the quarter and half year ended September 30, 2022. It is addressed to the National Stock Exchange of India and references SEBI regulations. The document does not contain the financial results themselves but is an intimation of the upcoming board meeting where these results will be approved. The document length is short (2259 characters) and serves as an announcement rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other categories like Interim Report or Earnings Release, which would require actual financial data or results.
2022-10-27 English
General updates
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted to the National Stock Exchange of India for the quarter ended September 30, 2022, pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It confirms procedural compliance related to dematerialization of securities and updating of registers. The document is short (2870 characters) and primarily serves as a certification or attestation rather than containing substantive financial data or detailed report content. It does not present financial statements or management discussion but is a regulatory compliance certificate. According to the Certification Rule, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS) rather than as an Interim Report or other financial report types.
2022-10-06 English
Annual General Meeting
Regulatory Filings
2022-10-01 English
Annual General Meeting
AGM Information Classification · 95% confidence The document is titled as "SUBMISSION OF THE PROCEEDINGS OF THE 15TH ANNUAL GENERAL MEETING HELD ON FRIDAY, SEPTEMBER 30, 2022." It details the proceedings of the AGM including attendance, resolutions passed, and voting results. It is a formal record of what transpired during the AGM rather than the AGM presentation materials or voting results alone. The document is about the meeting proceedings, which is distinct from the Annual Report or other financial reports. The document length is 6851 characters, which is sufficient to contain detailed proceedings. Therefore, the document fits the category of AGM Information (AGM-R).
2022-10-01 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. It specifically mentions the trading window closure period related to the upcoming declaration of the company's un-audited financial results for the quarter ending September 30, 2022. The document is an announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release itself. It does not contain financial data or results but is a regulatory notification to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-09-29 English
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the publication of a newspaper advertisement for the Notice of the 15th Annual General Meeting (AGM) of Vaishali Pharma Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 47 and Regulation 30, which pertain to the dissemination of notices for shareholder meetings. The content is about the announcement and publication of the AGM notice in newspapers, not the AGM materials themselves or the meeting minutes. The document length is 8331 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as an AGM Information announcement related to the AGM notice publication.
2022-09-09 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.